{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:52:29Z","timestamp":1787997149003,"version":"build-2784847793"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.antiviral.2016.10.016","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T20:09:56Z","timestamp":1479845396000},"page":"86-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study"],"prefix":"10.1016","volume":"138","author":[{"given":"Ana Bela","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8431-9718","authenticated-orcid":false,"given":"Joana","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Pinho Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Campilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Branca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Ant\u00f3nio","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Baldaque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boutolleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5795-2131","authenticated-orcid":false,"given":"Hugo","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.10.016_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.humimm.2004.02.007","article-title":"Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs","volume":"65","author":"Baldanti","year":"2004","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.antiviral.2016.10.016_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2006.05.002","article-title":"Antiviral drugs for cytomegalovirus diseases","volume":"71","author":"Biron","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.10.016_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2011.04.015","article-title":"Genotypic characterization of human cytomegalovirus UL97 phosphotransferase natural polymorphism in the era of ganciclovir and maribavir","volume":"91","author":"Boutolleau","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.10.016_bib4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2008.11.003","article-title":"Resistance pattern of cytomegalovirus (CMV) after oral valganciclovir therapy in transplant recipients at high-risk for CMV infection","volume":"81","author":"Boutolleau","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.10.016_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/rmv.1873","article-title":"Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art","volume":"26","author":"Campos","year":"2016","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2016.10.016_bib6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/tid.12311","article-title":"The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations","volume":"16","author":"Choi","year":"2014","journal-title":"Transpl. Infect. Dis. Official J. Transplant. Soc."},{"key":"10.1016\/j.antiviral.2016.10.016_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1034\/j.1399-3062.1999.010204.x","article-title":"Antiviral drug resistance in human cytomegalovirus","volume":"1","author":"Chou","year":"1999","journal-title":"Transpl. Infect. Dis. Official J. Transplant. Soc."},{"key":"10.1016\/j.antiviral.2016.10.016_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/rmv.574","article-title":"Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir","volume":"18","author":"Chou","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2016.10.016_bib9","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/AAC.00186-10","article-title":"Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistance","volume":"54","author":"Chou","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.10.016_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcv.2011.01.004","article-title":"Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy","volume":"50","author":"Chou","year":"2011","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.10.016_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/QCO.0000000000000170","article-title":"Approach to drug-resistant cytomegalovirus in transplant recipients","volume":"28","author":"Chou","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.016_bib12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/infdis\/jit654","article-title":"Phenotypic evaluation of previously uncharacterized cytomegalovirus DNA polymerase sequence variants detected in a valganciclovir treatment trial","volume":"209","author":"Chou","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.016_bib13","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1128\/AAC.00511-13","article-title":"Cytomegalovirus UL97 kinase catalytic domain mutations that confer multidrug resistance","volume":"57","author":"Chou","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.10.016_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/infdis\/172.1.239","article-title":"Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates","volume":"172","author":"Chou","year":"1995","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.016_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3851\/IMP2818","article-title":"Management of multidrug-resistant CMV infection in immunocompromised patients: case report of a heart-transplant recipient and review of the literature","volume":"20","author":"Deback","year":"2015","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2016.10.016_bib16","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1128\/JCM.02205-14","article-title":"Characterization of multiple cytomegalovirus drug resistance mutations detected in a hematopoietic stem cell transplant recipient by recombinant phenotyping","volume":"52","author":"Drouot","year":"2014","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2016.10.016_bib17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.bmt.1703666","article-title":"Rapid development of ganciclovir-resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery","volume":"30","author":"Eckle","year":"2002","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.antiviral.2016.10.016_bib18","first-page":"51","article-title":"Ganciclovir resistance mutations in UL97 and UL54 genes of Human cytomegalovirus isolates resistant to ganciclovir","volume":"48","author":"Foulongne","year":"2004","journal-title":"Acta Virol."},{"key":"10.1016\/j.antiviral.2016.10.016_bib19","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1128\/AAC.00334-11","article-title":"Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet","volume":"55","author":"Gilbert","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.10.016_bib20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/AAC.49.3.873-883.2005","article-title":"Human cytomegalovirus resistance to antiviral drugs","volume":"49","author":"Gilbert","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.10.016_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.csbj.2015.01.003","article-title":"Antiviral drug- and multidrug resistance in cytomegalovirus infected SCT patients","volume":"13","author":"Gohring","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.antiviral.2016.10.016_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jcv.2013.01.003","article-title":"Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation","volume":"57","author":"Gohring","year":"2013","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.10.016_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/tid.12200","article-title":"UL54 foscarnet mutation in an hematopoietic stem cell transplant recipient with cytomegalovirus disease","volume":"16","author":"Gregg","year":"2014","journal-title":"Transpl. Infect. Dis. Official J. Transplant. Soc."},{"key":"10.1016\/j.antiviral.2016.10.016_bib24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/QCO.0b013e32834cfb58","article-title":"The biology of cytomegalovirus drug resistance","volume":"24","author":"Hakki","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.016_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/346240","article-title":"Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfalls of phenotypic diagnosis by in\u00a0vitro selection of an UL97 mutant strain","volume":"187","author":"Hamprecht","year":"2003","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.016_bib26","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkq368","article-title":"Drug-resistant cytomegalovirus in transplant recipients: a French cohort study","volume":"65","author":"Hantz","year":"2010","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2016.10.016_bib27","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/tid.12241","article-title":"Cytomegalovirus antiviral resistance: characterization of results from clinical specimens","volume":"16","author":"Kleiboeker","year":"2014","journal-title":"Transpl. Infect. Dis. Official J. Transplant. Soc."},{"key":"10.1016\/j.antiviral.2016.10.016_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2013.10.011","article-title":"Resistance of human cytomegalovirus to ganciclovir\/valganciclovir: a comprehensive review of putative resistance pathways","volume":"101","author":"Komatsu","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.10.016_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"25","author":"Ljungman","year":"2011","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.antiviral.2016.10.016_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jcv.2006.11.005","article-title":"Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients","volume":"38","author":"Marfori","year":"2007","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.10.016_bib31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcv.2010.01.009","article-title":"Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis","volume":"47","author":"Martin","year":"2010","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2016.10.016_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1517\/14656560802678138","article-title":"Antiviral treatment of cytomegalovirus infection and resistant strains","volume":"10","author":"Schreiber","year":"2009","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.antiviral.2016.10.016_bib33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/infdis\/jit475","article-title":"High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantation","volume":"209","author":"Shmueli","year":"2014","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.10.016_bib34","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.bbmt.2014.08.010","article-title":"Cytomegalovirus infection in patients who underwent allogeneic hematopoietic stem cell transplantation in Portugal: a five-year retrospective review","volume":"20","author":"Sousa","year":"2014","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T17:47:39Z","timestamp":1549907259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216303291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":34,"alternative-id":["S0166354216303291"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.10.016","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}